Developing Story: Beyond Camizestrant — The Evolving Landscape of ER+/HER2- MBC with Dr. Sarah Premji
Clinical Trials, Treatment Decisions, Expert Interviews, Cancer Biology, Patient Education, Hope and Survivorship, Living with MBC, Patient Empowerment, FDA LiveFromStage4 Podcast Clinical Trials, Treatment Decisions, Expert Interviews, Cancer Biology, Patient Education, Hope and Survivorship, Living with MBC, Patient Empowerment, FDA LiveFromStage4 Podcast

Developing Story: Beyond Camizestrant — The Evolving Landscape of ER+/HER2- MBC with Dr. Sarah Premji

The oral SERD era has arrived, and the treatment landscape for HR+/HER2- metastatic breast cancer is changing fast. Hosts Victoria Goldberg and Abigail Johnston sit down with Dr. Sarah Premji of Sarah Cannon to map out what has shifted beyond SERENA-6, from new FDA approvals and emerging mechanisms to real-world sequencing decisions and the latest trial data. If you are trying to make sense of a rapidly evolving algorithm, this episode is for you.

Read More